ロード中...
Alleviation of cisplatin‐induced hepatotoxicity by gliclazide: Involvement of oxidative stress and caspase‐3 activity
AIMS: Cisplatin (CP), as an effective alkylating agent, is widely used in cancer treatment, while hepatotoxicity is one of its side effects. Gliclazide (GLZ), as an oral hypoglycemic drug, has antioxidant and anti‐inflammatory properties. This study was designed to investigate the protective effect...
保存先:
| 出版年: | Pharmacol Res Perspect |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8130655/ https://ncbi.nlm.nih.gov/pubmed/34003600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.788 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|